← All organizations
Highest phase reached
Phase 2
First clinical trial
Apr 1, 2009Last known activity
Jun 1, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (10 distinct, 5 trials)
Phase 2 (9 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Recent trials (9)
- NCT06846424Sponsor investigatorPhase 1Jun 1, 2025
- NCT06846424Lead sponsorPhase 1Jun 1, 2025
- NCT06602063Lead sponsorPhase 1/Phase 2Oct 31, 2024
- NCT05200260Lead sponsorPhase 2Feb 28, 2022
- NCT03983226Overall official - principal investigatorPhase 2Jul 31, 2019
- NCT03983226Lead sponsorPhase 2Jul 31, 2019
- NCT03983226Study chairPhase 2Jul 31, 2019
- NCT01669226Lead sponsorPhase 2Apr 1, 2009
- NCT01669226Overall official - principal investigatorPhase 2Apr 1, 2009
Details
- Last known activity
- Jun 1, 2025